Emerging evidences have shown that the NLRP3 inflammasome-mediated inflammatory cytokines play a key role in the pathogenesis of metabolic disorders such as diabetes, obesity, and MASLD [6–9]. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatotic liver disease.